Treatment With Antidepressants Increases Insulin-Like Growth Factor-I in Cerebrospinal Fluid
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Schilling, Claudia MD; Blum, Werner F. MD; Heuser, Isabella MD; Paslakis, Georgios MD; Wudy, Stefan A. MD; Deuschle, Michael MD Author Information
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, IGF-1 was high in cerebrospinal fluid of antidepressant-treated patients (Schilling et al. 2011).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Schilling et al. 2011
Citations
Cites
Ding, Q., Vaynman, S., Akhavan, M., Ying, Z., & Gomez-Pinilla, F. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.084 · Cited by 555
Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.007 · Cited by 348
Trejo, J. L., LLorens-Martín, M. V., & Torres-Alemán, I. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.10.016 · Cited by 288
Wada, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r02cr · Cited by 128
Duman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
Malberg, J. E., Platt, B., Rizzo, S. J. S., Ring, R. H., Lucki, I., Schechter, L. E., & Rosenzweig-Lipson, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301358 · Cited by 101
Central effects of the somatotropic system
Schneider, H., Pagotto, U., & Stalla, G. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490377 · Cited by 101
Chen, M. J., & Russo-Neustadt, A. A. (2007) · Growth Factors · doi:10.1080/08977190701602329 · Cited by 86
Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients
Deuschle, M., Blum, W. F., Strasburger, C. J., Schweiger, U., Weber, B., Körner, A., Standhardt, H., Gotthardt, U., Schmider, J., Pflaum, C. D., et al. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00046-2 · Cited by 83
Self-citationEngesser-Cesar, C., Anderson, A. J., & Cotman, C. W. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.016 · Cited by 80
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission
Hoshaw, B. A., Hill, T. I., Crowley, J. J., Malberg, J. E., Khawaja, X., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.023 · Cited by 60
Bezchlibnyk, Y. B., Li, X., Wang, J., & Young, L. T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.147 · Cited by 41
Weber-Hamann, B., Blum, W., Kratzsch, J., Gilles, M., Heuser, I., & Deuschle, M. (2009) · Pharmacopsychiatry · doi:10.1055/s-0028-1085442 · Cited by 39
Self-citationRupprecht, R., Rupprecht, C., Rupprecht, M., Noder, M., Lesch, K., & Mössner, J. (1989) · Journal of Affective Disorders · doi:10.1016/0165-0327(89)90018-9 · Cited by 24
GH, IGF-I, IGFBP-3 and IGFBP-2 in cerebrospinal fluid of infants, during puberty and in adults
Heinze, E., Boker, M., Blum, W. F. P., Behnisch, W., Schulz, A., Urban, J., & Mauch, E. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211976 · Cited by 21
Self-citation
Cited by
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
Quipildor, G. F., Mao, K., Hu, Z., Novaj, A., Cui, M., Gulinello, M. E., Branch, C. A., Gubbi, S., Patel, K., Moellering, D. R., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00065-3 · Cited by 90
Rusch, H. L., Guardado, P., Baxter, T., Mysliwiec, V., & Gill, J. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4770 · Cited by 79
“20 In the sole study of IGF-1 in patients with PTSD, pretreatment IGF-1 concentrations did not differ between PTSD patients and trauma-exposed controls; moreover, there was not a significant pre-post treatment change in PTSD patients whose symptoms remitted with paroxetine.”
IGF-I in major depression and antidepressant treatment response
Kopczak, A., Stalla, G. K., Uhr, M., Lucae, S., Hennings, J., Ising, M., Holsboer, F., & Kloiber, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.013 · Cited by 63
Metadata
- Authors
- Schilling, C., Blum, W. F., Heuser, I., Paslakis, G., Wudy, S. A., & Deuschle, M.
- Affiliations
- Eli Lilly (Germany) (DE)
- Central Institute of Mental Health (DE)
- Justus-Liebig-Universität Gießen (DE)
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2011-06
- Volume
- 31
- Issue
- 3
- Pages
- 390-392
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2328576116
- Cited by
- 29
- References
- 15
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- antidepressants, insulin-like growth factor I, cerebrospinal fluid, antidepressant treatment, neuroendocrine effects
- MeSH terms
- Adult, Aged, Antidepressive Agents, Clinical Trials as Topic, Major Depressive Disorder, Female, Humans, Insulin-Like Growth Factor I, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.